Abstract
Osteoarthritis and sarcopenia are the most frequently described musculoskeletal disorders in older persons but the intertwining of these conditions and of their functional and cellular causes is complex. This narrative review aims to identify the links between osteoarthritis and sarcopenia described 1-in clinical studies, 2-in in vitro studies, and 3-the available treatment strategies for both conditions. Electronic databases were used for the literature search of all studies investigating the relationship between sarcopenia and the presence of concomitant osteoarthritis. This review identified a limited number of clinical and morphometric studies on the complex relationship between osteoarthritis and sarcopenia. Studies present a number of methodological limitations due to definition and assessment of both entities. Low lean mass is one of the main actors of this cross-talk between muscle and bone, and adipose tissue plays a major role that had been underestimated. Bone Morphogenetic Proteins and myostatin pathways are key mediators and play an important role in both muscle and bone homeostasis. Common therapeutic recommendations are still missing. There is a need for good quality prospective studies on concomitant sarcopenia and osteoarthritis, more translational research, and pharmacological and non-pharmacological therapies in order to identify common denominators for the management of sarcopenia, osteoarthritis, and their comorbidities.
Similar content being viewed by others
Data Availability
Not applicable.
Code Availability
Not applicable.
References
Jeanmaire C, Mazières B, Verrouil E et al (2018) Body composition and clinical symptoms in patients with hip or knee osteoarthritis: results from the KHOALA cohort. Semin Arthritis Rheum 47:797–804. https://doi.org/10.1016/j.semarthrit.2017.10.012
Lewis R, Gómez Álvarez CB, Rayman M et al (2019) Strategies for optimising musculoskeletal health in the 21st century. BMC Musculoskelet Disord 20:1. https://doi.org/10.1186/s12891-019-2510-7
Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis. Age Ageing 39:412–423. https://doi.org/10.1093/ageing/afq034
Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31. https://doi.org/10.1093/ageing/afy169
Chen L-K, Liu L-K, Woo J et al (2014) Sarcopenia in Asia: consensus Report of the Asian Working Group for sarcopenia. J Am Med Dir Assoc 15:95–101. https://doi.org/10.1016/j.jamda.2013.11.025
Beaudart C, McCloskey E, Bruyère O et al (2016) Sarcopenia in daily practice: assessment and management. BMC Geriatr 16:170. https://doi.org/10.1186/s12877-016-0349-4
Dent E, Morley JE, Cruz-Jentoft AJ et al (2018) International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging 22:1148–1161. https://doi.org/10.1007/s12603-018-1139-9
Walrand S, Guillet C, Salles J et al (2011) Physiopathological mechanism of sarcopenia. Clin Geriatr Med 27:365–385. https://doi.org/10.1016/j.cger.2011.03.005
Tournadre A, Pereira B, Dutheil F et al (2017) Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis. J Cachexia Sarcopenia Muscle 8:639–646. https://doi.org/10.1002/jcsm.12189
Tarantino U, Scimeca M, Piccirilli E et al (2015) Sarcopenia: a histological and immunohistochemical study on age-related muscle impairment. Aging Clin Exp Res 27:51–60. https://doi.org/10.1007/s40520-015-0427-z
Choi Y-S, Kim M-J, Lee G-Y et al (2019) The association between frailty and disability among the elderly in rural areas of Korea. Int J Environ Res Public Health 16:2481. https://doi.org/10.3390/ijerph16142481
Greco EA, Pietschmann P, Migliaccio S (2019) Osteoporosis and sarcopenia increase frailty syndrome in the elderly. Front Endocrinol (Lausanne). https://doi.org/10.3389/fendo.2019.00255
Beaudart C, Bruyère O, Cruz-Jentoft AJ et al (2020) Patient’s engagement in the identification of critical outcomes in sarcopenia. J Am Med Dir Assoc 21:284–286. https://doi.org/10.1016/j.jamda.2019.09.004
Hiligsmann M, Beaudart C, Bruyère O et al (2020) Outcome priorities for older persons with sarcopenia. J Am Med Dir Assoc 21:267–271.e2. https://doi.org/10.1016/j.jamda.2019.08.026
Cesari M (2019) The frailty phenotype and sarcopenia: Similar but not the same. Aging Med (Milton) 2:97–98. https://doi.org/10.1002/agm2.12070
Sornay-Rendu E, Duboeuf F, Boutroy S, Chapurlat R (2017) Muscle mass is associated with incident fracture in postmenopausal women: the OFELY study. Bone 94:108–113. https://doi.org/10.1016/j.bone.2016.10.024
Rizzoli R, Reginster J-Y, Arnal J-F et al (2013) Quality of life in sarcopenia and frailty. Calcif Tissue Int 93:101–120. https://doi.org/10.1007/s00223-013-9758-y
Sayer AA, Robinson SM, Patel HP et al (2013) New horizons in the pathogenesis, diagnosis and management of sarcopenia. Age Ageing 42:145–150. https://doi.org/10.1093/ageing/afs191
Cruz-Jentoft AJ, Landi F, Schneider SM et al (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43:748–759. https://doi.org/10.1093/ageing/afu115
Bischoff-Ferrari HA, Orav JE, Kanis JA et al (2015) Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int 26:2793–2802. https://doi.org/10.1007/s00198-015-3194-y
Morley JE, Anker SD, von Haehling S (2014) Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology—update 2014. J Cachexia Sarcopenia Muscle 5:253–259. https://doi.org/10.1007/s13539-014-0161-y
von Haehling S, Morley JE, Anker SD (2010) An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle 1:129–133. https://doi.org/10.1007/s13539-010-0014-2
Beaudart C, Rolland Y, Cruz-Jentoft AJ et al (2019) Assessment of muscle function and physical performance in daily clinical practice : a position paper endorsed by the European Society for Clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Calcif Tissue Int 105:1–14. https://doi.org/10.1007/s00223-019-00545-w
van der Spoel E, van Vliet NA, van Heemst D (2019) Viewpoint on the role of tissue maintenance in ageing: focus on biomarkers of bone, cartilage, muscle, and brain tissue maintenance. Ageing Res Rev 56:100964. https://doi.org/10.1016/j.arr.2019.100964
Dodds RM, Murray JC, Robinson SM, Sayer AA (2020) The identification of probable sarcopenia in early old age based on the SARC-F tool and clinical suspicion: findings from the 1946 British birth cohort. Eur Geriatr Med. https://doi.org/10.1007/s41999-020-00310-5
Clark BC, Manini TM (2008) Sarcopenia ≠ Dynapenia. J Gerontol A Biol Sci Med Sci 63:829–834. https://doi.org/10.1093/gerona/63.8.829
Clark BC, Manini TM (2012) What is dynapenia? Nutrition 28:495–503. https://doi.org/10.1016/j.nut.2011.12.002
Tieland M, Trouwborst I, Clark BC (2018) Skeletal muscle performance and ageing. J Cachexia Sarcopenia Muscle 9:3–19. https://doi.org/10.1002/jcsm.12238
Terracciano C, Celi M, Lecce D et al (2013) Differential features of muscle fiber atrophy in osteoporosis and osteoarthritis. Osteoporos Int 24:1095–1100. https://doi.org/10.1007/s00198-012-1990-1
Guillemin F, Rat AC, Mazieres B et al (2011) Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey1. Osteoarthr Cartil 19:1314–1322. https://doi.org/10.1016/j.joca.2011.08.004
Chapple CM, Nicholson H, Baxter GD, Abbott JH (2011) Patient characteristics that predict progression of knee osteoarthritis: a systematic review of prognostic studies. Arthritis Care Res 63:1115–1125. https://doi.org/10.1002/acr.20492
Kim C, Linsenmeyer KD, Vlad SC et al (2014) Prevalence of radiographic and symptomatic hip osteoarthritis in an Urban United States Community: the Framingham Osteoarthritis study. Arthritis Rheumatol 66:3013–3017. https://doi.org/10.1002/art.38795
Hart DJ, Spector TD (1993) The relationship of obesity, fat distribution and osteoarthritis in women in the general population: the Chingford Study. J Rheumatol 20:331–335
Rezuș E, Cardoneanu A, Burlui A et al (2019) The link between inflammaging and degenerative joint diseases. Int J Mol Sci 20:614. https://doi.org/10.3390/ijms20030614
Scott D, Blizzard L, Fell J, Jones G (2012) Prospective study of self-reported pain, radiographic osteoarthritis, sarcopenia progression, and falls risk in community-dwelling older adults. Arthritis Care Res 64:30–37. https://doi.org/10.1002/acr.20545
Park HM, Kim HJ, Lee B et al (2018) Decreased muscle mass is independently associated with knee pain in female patients with radiographically mild osteoarthritis: a nationwide cross-sectional study (KNHANES 2010–2011). Clin Rheumatol 37:1333–1340. https://doi.org/10.1007/s10067-017-3942-9
Papalia R, Zampogna B, Torre G et al (2014) Sarcopenia and its relationship with osteoarthritis: risk factor or direct consequence? Musculoskelet Surg 98:9–14. https://doi.org/10.1007/s12306-014-0311-6
Lee JY, Han K, McAlindon TE et al (2016) Lower leg muscle mass relates to knee pain in patients with knee osteoarthritis. Int J Rheumatic Dis 21:126–133. https://doi.org/10.1111/1756-185X.12896
Suh DH, Han KD, Hong JY et al (2016) Body composition is more closely related to the development of knee osteoarthritis in women than men: a cross-sectional study using the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-1, 2). Osteoarthr Cartil 24:605–611. https://doi.org/10.1016/j.joca.2015.10.011
Lee SY, Ro HJ, Chung SG et al (2016) Low skeletal muscle mass in the lower limbs is independently associated to knee osteoarthritis. PLoS ONE. https://doi.org/10.1371/journal.pone.0166385
Kim SR, Choi K-H, Jung G-U et al (2016) Associations between fat mass, lean mass, and knee osteoarthritis: the Fifth Korean National Health and Nutrition Examination Survey (KNHANES V). Calcif Tissue Int 99:598–607. https://doi.org/10.1007/s00223-016-0190-y
Toda Y, Segal N, Toda T et al (2000) A decline in lower extremity lean body mass per body weight is characteristic of women with early phase osteoarthritis of the knee. J Rheumatol 27:2449–2454
Lee S, Kim T-N, Kim S-H (2012) Sarcopenic obesity is more closely associated with knee osteoarthritis than is nonsarcopenic obesity: a cross-sectional study. Arthritis Rheum 64:3947–3954. https://doi.org/10.1002/art.37696
Kim H-T, Kim H-J, Ahn H-Y, Hong Y-H (2016) An analysis of age-related loss of skeletal muscle mass and its significance on osteoarthritis in a Korean population. Korean J Intern Med 31:585–593. https://doi.org/10.3904/kjim.2015.156
Bae E-J, Kim Y-H (2017) Factors affecting sarcopenia in Korean adults by age groups. Osong Public Health Res Perspect 8:169–178. https://doi.org/10.24171/j.phrp.2017.8.3.03
Kemmler W, Teschler M, Goisser S et al (2015) Prevalence of sarcopenia in Germany and the corresponding effect of osteoarthritis in females 70 years and older living in the community: results of the FORMoSA study. Clin Interv Aging 10:1565–1573. https://doi.org/10.2147/CIA.S89585
Misra D (2019) Sarcopenic obesity: an undefined dilemma. Osteoarthr Cartil 27:1729–1730. https://doi.org/10.1016/j.joca.2019.06.006
Stenholm S, Harris TB, Rantanen T et al (2008) Sarcopenic obesity - definition, etiology and consequences. Curr Opin Clin Nutr Metab Care 11:693–700. https://doi.org/10.1097/MCO.0b013e328312c37d
Courties A, Berenbaum F, Sellam J (2019) The phenotypic approach to osteoarthritis: a look at metabolic syndrome-associated osteoarthritis. Joint Bone Spine 86:725–730. https://doi.org/10.1016/j.jbspin.2018.12.005
Kim M-J, Kang B-H, Park S-H et al (2020) Association of the western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) with Muscle Strength in Community-Dwelling Elderly with knee osteoarthritis. Int J Environ Res Public Health 17:2260. https://doi.org/10.3390/ijerph17072260
Misra D, Fielding RA, Felson DT et al (2019) Risk of knee osteoarthritis with obesity, sarcopenic obesity, and sarcopenia. Arthritis Rheumatol 71:232–237. https://doi.org/10.1002/art.40692
Shorter E, Sannicandro AJ, Poulet B, Goljanek-Whysall K (2019) Skeletal muscle wasting and its relationship with osteoarthritis: a mini-review of mechanisms and current interventions. Curr Rheumatol Rep. https://doi.org/10.1007/s11926-019-0839-4
Shere C, Fuggle NR, Edward MH et al (2020) Jumping joints: the complex relationship between osteoarthritis and jumping mechanography. Calcif Tissue Int 106:115–123. https://doi.org/10.1007/s00223-019-00622-0
Blumenfeld O, Williams FMK, Hart DJ et al (2013) Lower limbs composition and radiographic knee osteoarthritis (RKOA) in Chingford sample—a longitudinal study. Arch Gerontol Geriatr 56:148–154. https://doi.org/10.1016/j.archger.2012.09.006
Vlietstra L, Stebbings S, Meredith-Jones K et al (2019) Sarcopenia in osteoarthritis and rheumatoid arthritis: The association with self-reported fatigue, physical function and obesity. PLoS ONE. https://doi.org/10.1371/journal.pone.0217462
Landi F, Cesari M, Calvani R et al (2017) The “sarcopenia and physical fRailty IN older people: multi-component treatment strategies” (SPRINTT) randomized controlled trial: design and methods. Aging Clin Exp Res 29:89–100. https://doi.org/10.1007/s40520-016-0715-2
Biolo G, Cederholm T, Muscaritoli M (2014) Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr 33:737–748. https://doi.org/10.1016/j.clnu.2014.03.007
Jurk D, Wilson C, Passos JF et al (2014) Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat Commun. https://doi.org/10.1038/ncomms5172
Santos MLAS, Gomes WF, Pereira DS et al (2011) Muscle strength, muscle balance, physical function and plasma interleukin-6 (IL-6) levels in elderly women with knee osteoarthritis (OA). Arch Gerontol Geriatr 52:322–326. https://doi.org/10.1016/j.archger.2010.05.009
Sartori R, Sandri M (2015) Bone and morphogenetic protein signalling and muscle mass. Curr Opin Clin Nutr Metab Care 18:215–220. https://doi.org/10.1097/MCO.0000000000000172
Huang H-Y, Zhang W-T, Jiang W-Y et al (2015) RhoGDIβ inhibits bone morphogenetic protein 4 (BMP4)-induced adipocyte lineage commitment and favors smooth muscle-like cell differentiation. J Biol Chem 290:11119–11129. https://doi.org/10.1074/jbc.M114.608075
Zhao C, Shao Y, Lin C et al (2017) Myostatin serum concentrations are correlated with the severity of knee osteoarthritis. J Clin Lab Anal 31:e22094. https://doi.org/10.1002/jcla.22094
Scimeca M, Bonanno E, Piccirilli E et al (2015) Satellite cells CD44 positive drive muscle regeneration in osteoarthritis patients. In: Stem cells international. Available at https://www.hindawi.com/journals/sci/2015/469459/. Accessed 23 Apr 2020
Poonpet T, Honsawek S (2014) Adipokines: biomarkers for osteoarthritis? World J Orthop 5:319–327. https://doi.org/10.5312/wjo.v5.i3.319
Birch S, Lee MS, Robinson N, Alraek T (2017) The U.K. NICE 2014 guidelines for osteoarthritis of the knee: lessons learned in a narrative review addressing inadvertent limitations and bias. J Altern Complement Med 23:242–246. https://doi.org/10.1089/acm.2016.0385
McAlindon TE, Bannuru RR, Sullivan MC et al (2014) OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil 22:363–388. https://doi.org/10.1016/j.joca.2014.01.003
Molfino A, Amabile MI, Fanelli FR, Muscaritoli M (2016) Novel therapeutic options for cachexia and sarcopenia. Expert Opin Biol Ther 16:1239–1244. https://doi.org/10.1080/14712598.2016.1208168
Becker C, Lord SR, Studenski SA et al (2015) Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. Lancet Diabetes Endocrinol 3:948–957. https://doi.org/10.1016/S2213-8587(15)00298-3
Vinel C, Lukjanenko L, Batut A et al (2018) The exerkine apelin reverses age-associated sarcopenia. Nat Med 24:1360–1371. https://doi.org/10.1038/s41591-018-0131-6
Subramaniam K, Fallon K, Ruut T et al (2015) Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn’s disease. Aliment Pharmacol Ther 41:419–428. https://doi.org/10.1111/apt.13058
Zheng S, Hunter DJ, Xu J, Ding C (2016) Monoclonal antibodies for the treatment of osteoarthritis. Expert Opin Biol Thers 16:1529–1540. https://doi.org/10.1080/14712598.2016.1229774
Liu X, Zheng P, Wang X et al (2014) A preliminary evaluation of efficacy and safety of Wharton’s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cell Res Ther 5:1–9. https://doi.org/10.1186/scrt446
Florea V, Bagno L, Rieger AC, Hare JM (2019) Attenuation of frailty in older adults with mesenchymal stem cells. Mech Ageing Dev 181:47–58. https://doi.org/10.1016/j.mad.2019.111120
Huang R, Li W, Zhao Y et al (2020) Clinical efficacy and safety of stem cell therapy for knee osteoarthritis: A meta-analysis. Medicine 99:e19434. https://doi.org/10.1097/MD.0000000000019434
Thoumie P, Marty M, Avouac B et al (2018) Effect of unloading brace treatment on pain and function in patients with symptomatic knee osteoarthritis: the ROTOR randomized clinical trial. Sci Rep. https://doi.org/10.1038/s41598-018-28782-3
Krumov J, Obretenov V, Vodenicharova A et al (2019) The benefits to functional ambulation and physical activity of group-based rehabilitation in frail elderly Bulgarians undergoing total knee arthroplasty. Preliminary results. J Frailty Sarcopenia Falls 4:20–25. https://doi.org/10.22540/JFSF-04-020
Liao C-D, Tsauo J-Y, Chiu Y-S et al (2020) Effects of elastic resistance exercise after total knee replacement on muscle mass and physical function in elderly women with osteoarthritis: a randomized controlled trial. Am J Phys Med Rehabil 99:381–389. https://doi.org/10.1097/PHM.0000000000001344
Bruyère O, Cooper C, Pelletier J-P et al (2014) An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum 44:253–263. https://doi.org/10.1016/j.semarthrit.2014.05.014
Beaudart C, Dawson A, Shaw SC et al (2017) Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int 28:1817–1833. https://doi.org/10.1007/s00198-017-3980-9
Cuellar WA, Blizzard L, Hides JA et al (2019) Vitamin D supplements for trunk muscle morphology in older adults: secondary analysis of a randomized controlled trial. J Cachexia Sarcopenia Muscle 10:177–187. https://doi.org/10.1002/jcsm.12364
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
MEP and RC contributed equally to the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Marie-Eva Pickering and Roland Chapurlat declare that they have no conflict of interest.
Informed Consent
For this type of study formal consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pickering, ME., Chapurlat, R. Where Two Common Conditions of Aging Meet: Osteoarthritis and Sarcopenia. Calcif Tissue Int 107, 203–211 (2020). https://doi.org/10.1007/s00223-020-00703-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-020-00703-5